Literature DB >> 12062505

Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating.

Tatiana S Levchenko1, Ram Rammohan, Anatoly N Lukyanov, Kathleen R Whiteman, Vladimir P Torchilin.   

Abstract

The purpose of our work was to compare the biodistribution of liposomes with different surface properties. Phosphatidylcholine (PC)/cholesterol (Chol) liposomes were prepared containing 6% mol of a charged lipid (stearylamine, SA; phosphatidic acid, PA; or phosphatidyl serine, PS) and/or polyethylene glycol (PEG)-PE of different MW (750 and 5000). zeta-Potentials and liposome clearance in mice were investigated. In vitro, the attachment of PEG in a similar fashion neutralizes the effect of any charged component. In vivo, the chemical nature of a charged lipid becomes important. Both short PEG750 and longer PEG5000 inhibit the clearance of positively charged SA-liposomes, while only longer PEG5000 inhibits the clearance of negatively charged PA-liposomes and none of the PEGs inhibit the clearance of negatively charged PS-liposomes. The opsonins with different molecular size may be involved in the clearance of liposomes containing different charged lipids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062505     DOI: 10.1016/s0378-5173(02)00129-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  60 in total

1.  Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages.

Authors:  M M Janát-Amsbury; A Ray; C M Peterson; H Ghandehari
Journal:  Eur J Pharm Biopharm       Date:  2010-11-18       Impact factor: 5.571

2.  Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance.

Authors:  Rajendra S Kadam; David W A Bourne; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2012-04-12       Impact factor: 3.922

3.  Nanoprobes with near-infrared persistent luminescence for in vivo imaging.

Authors:  Quentin le Masne de Chermont; Corinne Chanéac; Johanne Seguin; Fabienne Pellé; Serge Maîtrejean; Jean-Pierre Jolivet; Didier Gourier; Michel Bessodes; Daniel Scherman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

4.  Plasma clearance of bacteriophage Qbeta particles as a function of surface charge.

Authors:  Duane E Prasuhn; Pratik Singh; Erica Strable; Steven Brown; Marianne Manchester; M G Finn
Journal:  J Am Chem Soc       Date:  2008-01-05       Impact factor: 15.419

5.  Creating functional vesicle assemblies from vesicles and nanoparticles.

Authors:  Robert J Mart; Kwan Ping Liem; Simon J Webb
Journal:  Pharm Res       Date:  2009-04-23       Impact factor: 4.200

Review 6.  Imaging of cells and nanoparticles: implications for drug delivery to the brain.

Authors:  Katica Stojanov; Inge S Zuhorn; Rudi A J O Dierckx; Erik F J de Vries
Journal:  Pharm Res       Date:  2012-07-18       Impact factor: 4.200

Review 7.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

8.  Theranostic Layer-by-Layer Nanoparticles for Simultaneous Tumor Detection and Gene Silencing.

Authors:  Natalie Boehnke; Santiago Correa; Liangliang Hao; Wade Wang; Joelle P Straehla; Sangeeta N Bhatia; Paula T Hammond
Journal:  Angew Chem Int Ed Engl       Date:  2020-01-07       Impact factor: 15.336

9.  Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells.

Authors:  Sourav Bhattacharjee; Laura H J de Haan; Nynke M Evers; Xue Jiang; Antonius T M Marcelis; Han Zuilhof; Ivonne M C M Rietjens; Gerrit M Alink
Journal:  Part Fibre Toxicol       Date:  2010-09-11       Impact factor: 9.400

Review 10.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.